EMA clears compassionate use of Gilead’s remdesivir for COVID-19

EMA clears compassionate use of Gilead’s remdesivir for COVID-19

Submitted by admin on April 7, 2020 - 7:42pm
Source: 
Pharmaforum
News Tags: 
Europe
EMA
Gilead Sciences
COVID-19
remdesivir
Headline: 
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
snippet: 

The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy.

Do Not Allow Advertisers to Use My Personal information